Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0I8CK
|
|||
| Former ID |
DIB013454
|
|||
| Drug Name |
IPL-512602
|
|||
| Synonyms |
BLX-LSAID; IPL-576 series; OX-LSAID; Lead LSAID (asthma), Biolipox; Lead LSAID (asthma), Orexo; Lead LSAID (asthma), Inflazyme/Aventis; Lead LSAID (asthma), Inflazyme/sanofi-aventis
Click to Show/Hide
|
|||
| Indication | Asthma [ICD-11: CA23; ICD-10: J45, J45.8; ICD-9: 493] | Phase 2 | [1] | |
| Company |
Inflazyme Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00330070) Control of Asthma Patients Symptomatic on Inhaled Corticosteroids. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.